These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 9740539)

  • 1. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
    Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
    Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine).
    Adams DJ; Knick VC
    Invest New Drugs; 1995; 13(1):13-21. PubMed ID: 7499103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markedly diminished drug resistance-inducing properties of vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro.
    Etiévant C; Kruczynski A; Barret JM; Tait AS; Kavallaris M; Hill BT
    Cancer Chemother Pharmacol; 2001 Jul; 48(1):62-70. PubMed ID: 11488526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
    Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
    J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
    Kruczynski A; Hill BT
    Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux.
    Vanhuyse M; Kluza J; Tardy C; Otero G; Cuevas C; Bailly C; Lansiaux A
    Cancer Lett; 2005 Apr; 221(2):165-75. PubMed ID: 15808402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A; Colpaert F; Tarayre JP; Mouillard P; Fahy J; Hill BT
    Cancer Chemother Pharmacol; 1998; 41(6):437-47. PubMed ID: 9554586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate.
    Leontieva OV; Preobrazhenskaya MN; Bernacki RJ
    Invest New Drugs; 2002 Feb; 20(1):35-48. PubMed ID: 12003193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein.
    Mayer LD; Lim KT; Hartley D
    J Exp Ther Oncol; 2002; 2(2):107-20. PubMed ID: 12415627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of a navelbine-resistant bladder carcinoma cell line cross-resistant to taxoids.
    Debal V; Allam N; Morjani H; Millot JM; Braguer D; Breillout F; Manfait M
    Br J Cancer; 1994 Dec; 70(6):1118-25. PubMed ID: 7981063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E; Tarasiuk J; Garnier-Suillerot A
    Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells.
    Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M
    J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumvention of P-glycoprotein-mediated multidrug resistance by S16020-2: kinetics of uptake and efflux in sensitive and resistant cell lines.
    Pierré A; Léonce S; Pérez V; Atassi G
    Cancer Chemother Pharmacol; 1998; 42(6):454-60. PubMed ID: 9788571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
    Hill BT; Whelan RD; Shellard SA; McClean S; Hosking LK
    Invest New Drugs; 1994; 12(3):169-82. PubMed ID: 7896535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
    Wang L; Kitaichi K; Hui CS; Takagi K; Takagi K; Sakai M; Yokogawa K; Miyamoto KI; Hasegawa T
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):587-93. PubMed ID: 10901387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells.
    Wang FP; Wang L; Yang JS; Nomura M; Miyamoto K
    Biol Pharm Bull; 2005 Oct; 28(10):1979-82. PubMed ID: 16204959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
    Loor F; Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Emmer G
    Br J Cancer; 1992 Jan; 65(1):11-8. PubMed ID: 1346365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).
    Jansson PJ; Yamagishi T; Arvind A; Seebacher N; Gutierrez E; Stacy A; Maleki S; Sharp D; Sahni S; Richardson DR
    J Biol Chem; 2015 Apr; 290(15):9588-603. PubMed ID: 25720491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
    Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
    Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.